The mission of the Office of Faculty Affairs is to provide support to Renaissance School of Medicine at Stony Brook University faculty, particularly in the areas of career advancement, faculty development, professional satisfaction, faculty mentoring and faculty diversity and inclusion.
Faculty Development Session: NIH Loan Forgiveness Program, presented by Dr. Sandeep Mallipattu
May 1 from 12-1pm on Zoom.
|
Carol A. Carter Elected to U.S. National Academy of Sciences
Carter is the 18th Stony Brook University faculty member elected to the NAS, and is only the second elected member from the RSOM. World-renowned virologist and Emeritus Professor in the Department of Microbiology and Immunology Eckard Wimmer was elected in 2012. “Carol has been active in translational research and has exploited her discoveries for the identification of new antiviral compounds,” said David Thanassi, professor and Zhang Family Endowed Chair of the Department of Microbiology and Immunology. “Her research illustrates the power of basic science to lead to unexpected insights and generate new avenues for therapeutic development.” Carter was one of 120 new members elected by their peers at the NAS annual meeting on April 30, bringing the total number of NAS members to 2,617 since the society’s inception in 1863. Approximately 500 NAS members have earned a Nobel Prize. “Frankly speaking, I’m stunned, thrilled and honored to be joining the company of those I have admired throughout my career,” said Carter. “This recognition from the Academy opens the door to the possibility of shining more light on feasible ways to approach targeting non-traditional cellular systems for drug discovery, systems that have long been exploited by viral pathogens for their production.” Carter is best known as an early pioneer in HIV research. At the onset of the AIDS pandemic, she advanced understanding of the viral-encoded protease and purified the viral capsid protein for structural and biochemical studies. She has also conducted research on Epstein-Barr Virus (EBV) and Severe Acute Respiratory Syndrome Coronavirus Virus-2 (SARS CoV-2), pathogens causing organ transplant rejection and COVID-19, respectively. In 2001, her groundbreaking research, published in PNAS, identified an interaction between HIV and a host protein (Tsg101) that is essential for the assembly and budding of HIV viral particles from infected cells. Her findings opened a new field of research on host factors in microbial pathogenesis and suggested the possibility of targeting host proteins for developing antimicrobial therapeutics, with implications beyond HIV. Carter has also served as a member of the National Institute of Allergy and Infectious Diseases Advisory Council from 2007 to 2011. She received the Stony Brook University Presidential Award for Promoting Diversity and Academic Excellence in 2013, and the Suffolk County, NY, Martin Luther King Jr Commission Public Service Award in 2016. Currently, she collaborates with Cold Spring Harbor Laboratory DNA Learning Center staff and Stony Brook Faculty in the RSOM, the School of Marine and Atmospheric Sciences, School of Health Professions, and the Office of Undergraduate Admissions, in efforts to mentor high school students interested in pursuing careers in health sciences professions. She continues her research focus on several areas, including the role of cellular proteins in assembly of HIV and other members of the Retrovirus family; Tsg101 structure/function analysis; and antiviral drug development, to name a few. Carol A. Carter received her PhD from Yale University in 1972. She has been a faculty member at Stony Brook University since 1975. Congratulations to 2023 School of Medicine Awards Winners!
Drs. Bettina C. Fries, Richard T. Mathias, and Sharon Nachman Appointed SUNY Distinguished Professors Congratulations to our new SUNY Distinguished Professors, Dr. Bettina C. Fries, Dr. Richard T. Mathias, and Dr. Sharon Nachman! Dr. Bettina Fries is chief of the Division of Infectious Diseases at Stony Brook Medicine, and is nationally recognized as a physician-scientist in the field of microbiology. She is a Professor of Medicine, Microbiology and Immunology at the Renaissance School of Medicine. She is also an attending at the Northport Veterans Affairs Medical Center. Nationally, Dr. Fries is a Fellow of the Infectious Disease Society and also a Member of the Academy of Microbiology of America. She has served as the President of the Infectious Diseases Society of New York from 2018-2019. She currently serves as the President of Medical Mycological Society of the Americas. Dr. Fries has received numerous extramural grant support, including 20 straight years of support by the National Institutes of Health. The primary focus of her research is on the pathogenesis of chronic fungal infections as well the development of monoclonal antibodies against multidrug-resistant bacteria. Dr. Richard T Mathias earned his BA and PhD degrees and his postdoctoral work in engineering from UCLA. He got his initial faculty appointment and rose through the faculty ranks at Rush Medical College in Chicago, and joined the Department of Physiology and Biophysics at SUNY Stony Brook in 1985 as a Professor. His research has focused on the Lens and the Heart. He has made important contributions both theoretically and experimentally into how the renin-angiotensin system controls contractility across the cardiac ventricular wall. He has also postulated a circulating current in the lens, which has led to increased understanding of the physiological basis of cataracts, and is now considered a dogma in the field. In 2017, he was awarded the Kinoshita Lectureship for career accomplishments in Lens Research. Dr. Mathias has achieved international recognition for his scientific research, and has enhanced both the international scientific community and Stony Brook University with his efforts. Dr. Sharon Nachman is an international leader in the area of pediatric infectious disease and the treatment of children with AIDS, flu and measles. She has been the principal investigator of more than 30 clinical trials of promising medicine for patients treated at Stony Brook University Hospital and conducted international trials in the areas of new vaccines, Lyme disease, and AIDS. She also directs the Maternal Child HIV/AIDS Program.
Dr. Dorothy Lane Receives 2023 Ronald Davis Special Recognition Award
Dr. Lane is a decorated physician and a fixture in the field of preventive medicine. She has spearheaded numerous research initiatives dedicated to advancing preventive medicine practices, particularly in the areas of women’s health and cancer screening. As founding director of the Stony Brook Residency Program in Public Health and General Preventive Medicine, she has mentored 142 medical practitioners. Dr. Lane has also published more than 200 articles in peer-reviewed journals. One of Dr. Lane’s leading initiatives while at Stony Brook was her role as principal investigator of the National Heart, Lung and Blood Institute Women’s Health Initiative Center (WHI) since its inception in 1994. Stony Brook Medicine was one of 40 national centers — and the only one based on Long Island — that conducted the landmark WHI study of the major causes of morbidity and mortality among postmenopausal women. She was principal investigator of a series, spanning 30 years, of National Cancer Institute–funded research projects focused on improving public and physician breast and colorectal cancer screening rates. Dr. Lane also directed one of the five initially funded Centers for Disease Control and Prevention colorectal cancer screening demonstration programs, which covered the cost of colonoscopy screenings for uninsured and underinsured health center patients in Suffolk County. Dr. Lane is a past president of the ACPM and served as chair of the American Board of Preventive Medicine and president of the Association of Teachers of Preventive Medicine. She was a member of the Board of Directors of the national Accreditation Council for Continuing Medical Education, and a member of the Board of Directors of the Accreditation Council for Graduate Medical Education. The Ronald Davis Special Recognition Award is named after the late Ronald Davis, MD, the first preventive medicine physician to serve as president of the American Medical Association. The award was first given in 2009 to former Surgeon General Dr. David Satcher. For a list of previous winners see this link. Dr. Sandeep Mallipattu elected to American Society for Clinical Investigation
An international organization with more than 3,000 physician-scientist members from all medical specialties, the ASCI is dedicated to the advancement of research that extends understanding of diseases and improves treatment. Members are also committed to mentoring future generations of physician-scientists. Dr. Mallipattu is only the 19th Stony Brook University faculty member elected to the ASCI, and the first since 2015. “The ASCI is among the few organizations focused on the special role of physician-scientists in research, clinical care, and medical education, as well as leadership positions in academic medicine and the life sciences industry,” said Vincent Yang, MD, PhD, the Simons Chair of Medicine. “Sandeep’s election is testimony of his research prowess and achievements.” Dr. Mallipattu has conducted groundbreaking research on the molecular mechanisms of chronic kidney disease and how these mechanisms catalyze the disease’s development and progression. He and colleagues have uncovered new details about kidney regulation and function, and advanced the science behind kidney regeneration. Women in Medicine Research Day
To download the complete program of the event, please click here. |
Faculty Mentoring Workshops
May 1, 2024: NIH Loan Forgiveness (Dr. Sandeep Mallipattu), 12-1pm, zoom To more information, please contact Kimberly Malamutt. |
17th Annual Women in Medicine Research Day will take place on March 6, 2023, 9am-2pm, in MART Auditorium. This year's event will feature a guest speaker Dr. Juanita Merchant, MD, PhD, Professor of Medicine and Chief of the Division of Gastroenterology at College of Medicine Tucson at University of Arizona. She will give a talk entitled "The HNF1A variant provides a genomic landscape for EO-CRC to develop in the setting of a specific diet type."
